Deal watch: Abbott and Neurocrine to develop promising endometriosis drug.
D002986:Clinical Trials as Topic; D003299:Cooperative Behavior; D015195:Drug Design; D004345:Drug Industry / Q000458:organization & administration; D004715:Endometriosis / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists / Q000037:antagonists & inhibitors*; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000494:pharmacology* / Q000627:therapeutic use; D011743:Pyrimidines / Q000494:pharmacology* / Q000627:therapeutic use
D006845:Hydrocarbons, Fluorinated; D011743:Pyrimidines; D007987:Gonadotropin-Releasing Hormone; C539351:elagolix